Conventional chemotherapy and oncogenic pathway targeting in ovarian carcinosarcoma using a patient-derived tumorgraft

about

Investigation of factors affecting the efficacy of 3C23K, a human monoclonal antibody targeting MISIIR.Comparison of first-line chemotherapy regimens for ovarian carcinosarcoma: a single institution case series and review of the literature.

P2860

Q47153253-C919E1B9-C9A7-4B8E-A419-765E79E834C0 Q50094270-533CEE15-EEBC-45F6-8BC5-BBDD9E9A5F02

P2860

Conventional chemotherapy and oncogenic pathway targeting in ovarian carcinosarcoma using a patient-derived tumorgraft

Item

http://www.wikidata.org/entity/Q35592388

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Conventional chemotherapy and ...... g a patient-derived tumorgraft

@ast

Conventional chemotherapy and ...... g a patient-derived tumorgraft

@en

type

Item

label

Conventional chemotherapy and ...... g a patient-derived tumorgraft

@ast

Conventional chemotherapy and ...... g a patient-derived tumorgraft

@en

prefLabel

Conventional chemotherapy and ...... g a patient-derived tumorgraft

@ast

Conventional chemotherapy and ...... g a patient-derived tumorgraft

@en

P1476

Conventional chemotherapy and ...... g a patient-derived tumorgraft

@en

P2093

Gretchen Glaser

http://www.w3.org/2001/XMLSchema#string

Marc A Becker

http://www.w3.org/2001/XMLSchema#string

S John Weroha

http://www.w3.org/2001/XMLSchema#string

Sean C Harrington

http://www.w3.org/2001/XMLSchema#string

Sergio Enderica-Gonzalez

http://www.w3.org/2001/XMLSchema#string

Xiaonan Hou

http://www.w3.org/2001/XMLSchema#string

P2860

NIH Image to ImageJ: 25 years of image analysis

Patient-derived tumour xenografts as models for oncology drug development

BRCAness: finding the Achilles heel in ovarian cancer

Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas

The Sequence Alignment/Map format and SAMtools

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial

Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.

The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial.

A phase II trial of ifosfamide and mesna in patients with advanced or recurrent mixed mesodermal tumors of the ovary previously treated with platinum-based chemotherapy: a Gynecologic Oncology Group study.

Humanized mouse model of ovarian cancer recapitulates patient solid tumor progression, ascites formation, and metastasis.

P304

e0126867

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0126867

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Paul Haluska

P577

2015-05-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276458909

http://www.w3.org/2001/XMLSchema#string

P698

25962155

http://www.w3.org/2001/XMLSchema#string

P932

4427104

http://www.w3.org/2001/XMLSchema#string

Conventional chemotherapy and oncogenic pathway targeting in ovarian carcinosarcoma using a patient-derived tumorgraft

about

P2860

P2860

Conventional chemotherapy and oncogenic pathway targeting in ovarian carcinosarcoma using a patient-derived tumorgraft

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932